Literature DB >> 29788347

Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic: The Sierra Leone Trial to Introduce a Vaccine Against Ebola.

Muhammad-Abbas Conteh1, Susan T Goldstein2, Haja R Wurie1, Jane Gidudu2, Durodami Radcliffe Lisk1, Rosalind J Carter2, Jane F Seward2, Lee M Hampton2, David Wang2, Lauren E Andersen2, Melissa Arvay2, Stephanie J Schrag2, Peter Dawson3, Augustin E Fombah1, Carey R Petrie3, Daniel R Feikin2, James B W Russell1, Robert Lindblad3, S A S Kargbo4, Mohamed Samai1, Barbara E Mahon2.   

Abstract

Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29788347      PMCID: PMC6927893          DOI: 10.1093/infdis/jiy061

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.

Authors:  Michael Garbutt; Ryan Liebscher; Victoria Wahl-Jensen; Steven Jones; Peggy Möller; Ralf Wagner; Viktor Volchkov; Hans-Dieter Klenk; Heinz Feldmann; Ute Ströher
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

2.  Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination.

Authors:  Lieselotte Cnops; Michèle Gerard; Olivier Vandenberg; Sigi Van den Wijngaert; Leo Heyndrickx; Elisabeth Willems; Kathy Demeulemeester; Hilde De Clerck; Anne Dediste; Steven Callens; Paul De Munter; Erika Vlieghe; Emmanuel Bottieau; Francoise Wuillaume; Marjan Van Esbroeck; Kevin K Ariën
Journal:  Clin Infect Dis       Date:  2015-02-18       Impact factor: 9.079

3.  Characteristics and survival of patients with Ebola virus infection, malaria, or both in Sierra Leone: a retrospective cohort study.

Authors:  Matthew Waxman; Adam R Aluisio; Soham Rege; Adam C Levine
Journal:  Lancet Infect Dis       Date:  2017-03-01       Impact factor: 25.071

4.  Clinical features of patients isolated for suspected Ebola virus disease at Connaught Hospital, Freetown, Sierra Leone: a retrospective cohort study.

Authors:  Marta Lado; Naomi F Walker; Peter Baker; Shamil Haroon; Colin S Brown; Daniel Youkee; Neil Studd; Quaanan Kessete; Rishma Maini; Tom Boyles; Eva Hanciles; Alie Wurie; Thaim B Kamara; Oliver Johnson; Andrew J M Leather
Journal:  Lancet Infect Dis       Date:  2015-07-23       Impact factor: 25.071

5.  Ebola Virus Diagnostics: The US Centers for Disease Control and Prevention Laboratory in Sierra Leone, August 2014 to March 2015.

Authors:  Mike Flint; Christin H Goodman; Scott Bearden; Dianna M Blau; Brian R Amman; Alison J Basile; Jessica A Belser; Éric Bergeron; Michael D Bowen; Aaron C Brault; Shelley Campbell; Ayan K Chakrabarti; Kimberly A Dodd; Bobbie R Erickson; Molly M Freeman; Aridth Gibbons; Lisa W Guerrero; John D Klena; R Ryan Lash; Michael K Lo; Laura K McMullan; Gbetuwa Momoh; James L Massally; Augustine Goba; Christopher D Paddock; Rachael A Priestley; Meredith Pyle; Mark Rayfield; Brandy J Russell; Johanna S Salzer; Angela J Sanchez; Amy J Schuh; Tara K Sealy; Martin Steinau; Robyn A Stoddard; Céline Taboy; Maryann Turnsek; David Wang; Galina E Zemtsova; Marko Zivcec; Christina F Spiropoulou; Ute Ströher; Jonathan S Towner; Stuart T Nichol; Brian H Bird
Journal:  J Infect Dis       Date:  2015-07-30       Impact factor: 5.226

6.  Ebola Surveillance - Guinea, Liberia, and Sierra Leone.

Authors:  Lucy A McNamara; Ilana J Schafer; Leisha D Nolen; Yelena Gorina; John T Redd; Terrence Lo; Elizabeth Ervin; Olga Henao; Benjamin A Dahl; Oliver Morgan; Sara Hersey; Barbara Knust
Journal:  MMWR Suppl       Date:  2016-07-08

7.  Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.

Authors:  Stephen B Kennedy; Fatorma Bolay; Mark Kieh; Greg Grandits; Moses Badio; Ripley Ballou; Risa Eckes; Mark Feinberg; Dean Follmann; Birgit Grund; Swati Gupta; Lisa Hensley; Elizabeth Higgs; Krisztina Janosko; Melvin Johnson; Francis Kateh; James Logue; Jonathan Marchand; Thomas Monath; Martha Nason; Tolbert Nyenswah; François Roman; Eric Stavale; Julian Wolfson; James D Neaton; H Clifford Lane
Journal:  N Engl J Med       Date:  2017-10-12       Impact factor: 91.245

8.  Improving burial practices and cemetery management during an Ebola virus disease epidemic - Sierra Leone, 2014.

Authors:  Carrie F Nielsen; Sarah Kidd; Ansumana R M Sillah; Edward Davis; Jonathan Mermin; Peter H Kilmarx
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-01-16       Impact factor: 17.586

Review 9.  The 117 call alert system in Sierra Leone: from rapid Ebola notification to routine death reporting.

Authors:  Charles Alpren; Mohamed F Jalloh; Reinhard Kaiser; Mariam Diop; Sas Kargbo; Evelyn Castle; Foday Dafae; Sara Hersey; John T Redd; Amara Jambai
Journal:  BMJ Glob Health       Date:  2017-09-07

10.  Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Authors:  Ana Maria Henao-Restrepo; Anton Camacho; Ira M Longini; Conall H Watson; W John Edmunds; Matthias Egger; Miles W Carroll; Natalie E Dean; Ibrahima Diatta; Moussa Doumbia; Bertrand Draguez; Sophie Duraffour; Godwin Enwere; Rebecca Grais; Stephan Gunther; Pierre-Stéphane Gsell; Stefanie Hossmann; Sara Viksmoen Watle; Mandy Kader Kondé; Sakoba Kéïta; Souleymane Kone; Eewa Kuisma; Myron M Levine; Sema Mandal; Thomas Mauget; Gunnstein Norheim; Ximena Riveros; Aboubacar Soumah; Sven Trelle; Andrea S Vicari; John-Arne Røttingen; Marie-Paule Kieny
Journal:  Lancet       Date:  2016-12-23       Impact factor: 79.321

View more
  2 in total

1.  The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Authors:  Mohamed Samai; Jane F Seward; Susan T Goldstein; Barbara E Mahon; Durodami Radcliffe Lisk; Marc-Alain Widdowson; Mohamed I Jalloh; Stephanie J Schrag; Ayesha Idriss; Rosalind J Carter; Peter Dawson; S A S Kargbo; Bailah Leigh; Mohamed Bawoh; Jennifer Legardy-Williams; Gibrilla Deen; Wendy Carr; Amy Callis; Robert Lindblad; James B W Russell; Carey R Petrie; Augustin E Fombah; Brima Kargbo; Wendi McDonald; Olamide D Jarrett; Robert E Walker; Paul Gargiullo; Donald Bash-Taqi; Laura Gibson; Abu Bakarr Fofanah; Anne Schuchat
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

Review 2.  Prevention of Emerging Infections in Children.

Authors:  Thanyawee Puthanakit; Suvaporn Anugulruengkitt; Watsamon Jantarabenjakul
Journal:  Pediatr Clin North Am       Date:  2022-02       Impact factor: 3.278

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.